Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.

about

Levodopa-induced Dyskinesia: Clinical Features, Pathophysiology, and Medical Management.Factors associated with motor complications in Parkinson's disease.L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey.

P2860

Q41626118-DDFCEEEA-ABF9-49D2-A333-FED00EF003AC Q42655862-B7F18497-A5FA-4720-9C3D-F85D08E85D51 Q47615634-8F47FCE8-CB74-4154-AC90-66A1A57FF106

P2860

Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.

Item

http://www.wikidata.org/entity/Q40860918

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.

@en

type

Item

label

Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.

@en

prefLabel

Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.

@en

P1476

Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.

@en

P2093

Gennarina Arabia

http://www.w3.org/2001/XMLSchema#string

Giovanni Iliceto

http://www.w3.org/2001/XMLSchema#string

Giovanni Mostile

http://www.w3.org/2001/XMLSchema#string

Giuseppe Nicoletti

http://www.w3.org/2001/XMLSchema#string

Paolo Lamberti

http://www.w3.org/2001/XMLSchema#string

Roberto Marconi

http://www.w3.org/2001/XMLSchema#string

P2860

The history of dopamine and levodopa in the treatment of Parkinson's disease

“Mini-mental state”

Parkinsonism: onset, progression and mortality

Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD

Association between early-onset Parkinson's disease and mutations in the parkin gene

Parkin disease: a clinicopathologic entity?

Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype.

Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature.

Diagnostic criteria for Parkinson disease.

Classifying risk factors for dyskinesia in Parkinson's disease.

P2888

s00415-016-8075-6

P304

888-894

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00415-016-8075-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

263

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26964541

http://www.w3.org/2001/XMLSchema#string

P921

levodopa

dyskinesia

Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.

about

P2860

P2860

Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921